Physician profile
Harshinder Singh
NPI 1003899857
$9,026.98
in general payments reported to CMS, 2019-2025
48 companies · $2,246 in 2025
The $2,246 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $823 · 2020: $818 · 2021: $1,363 · 2022: $830 · 2023: $1,378 · 2024: $1,569 · 2025: $2,246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,361 · Travel and Lodging: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,361.07 |
| Travel and Lodging | $830.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,023.25 | 2019-2025 | Varithena Administration Pack, Lux-Dx Insertable Cardiac Monitor, General - Tachy |
| Astrazeneca Pharmaceuticals Lp | $851.36 | 2019-2025 | Farxiga, Wainua |
| Medtronic, INC. | $822.04 | 2021-2025 | Venaseal, Aurora Ev-Icd Mri Surescan, Micra |
| Philips North America LLC | $644.09 | 2020-2025 | (Ck7) Extended Holter, (Ck4) Mcot, Laser Cvx300 |
| Novartis Pharmaceuticals Corporation | $621.26 | 2019-2025 | |
| Abbott Laboratories | $556.74 | 2019-2025 | Confirm Rx, Accent, Cardiomems |
| Boehringer Ingelheim Pharmaceuticals, INC. | $388.18 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $361.91 | 2019-2025 | Lifevest |
| Amarin Pharma, INC. | $308.46 | 2019-2021 | |
| Astellas Pharma US INC | $291.64 | 2019-2022 | |
| Pfizer INC. | $283.74 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $270.25 | 2019-2025 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $252.20 | 2022-2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $252.07 | 2021-2025 | Verquvo, Capvaxive |
| Angiodynamics, INC. | $247.63 | 2021 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harshinder Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.